Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Abbott Laboratories (NYSE:ABT) recently introduced the FreeStyle Libre 3 Plus in Canada, marking an advancement in diabetes management technology with its small, sensor-based glucose monitoring system ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.

The sensor patch market was valued at $1.6 billion in 2022, and is estimated to reach $56.4 billion by 2032, growing at a CAGR of 43.2% from 2023 to 2032. Proactive surge in manufacturing output, ...

AbbVie’s history stems from the late 19th century work of Chicago physician Wallace Calvin Abbott, whose small operation of ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

Find the latest information on Abbott Laboratories Common Stock (ABT) insider activity and insider shares traded to make sound investments with Nasdaq.com.